Citation: Jingmei Yuan, Mengran Guo, Shengnan Zhao, Jinhua Li, Xinchun Wang, Jian Yang, Zhaohui Jin, Xiangrong Song. Core-shell lipid-polymeric nanoparticles for enhanced oral bioavailability and antihypertensive efficacy of KY5 peptide[J]. Chinese Chemical Letters, ;2023, 34(4): 107943. doi: 10.1016/j.cclet.2022.107943 shu

Core-shell lipid-polymeric nanoparticles for enhanced oral bioavailability and antihypertensive efficacy of KY5 peptide

Jingmei Yuan ^{a, 1} ,
Mengran Guo ^{a, 1} ,
Shengnan Zhao ^b ,
Jinhua Li ^a ,
Xinchun Wang ^c ,
Jian Yang ^{b, *,} ,
Zhaohui Jin ^{a, *,} ,
Xiangrong Song ^{a, c, *,}

a.
Department of Critical Care Medicine, Department of Clinical Pharmacy, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China
b.
School of Applied Chemistry and Biological Technology, Shenzhen Polytechnic, Shenzhen 518055, China
c.
First Affiliated Hospital of the Medical College, Shihezi University, Shihezi 832008, China

jiany@szpt.edu.cn

695025422@qq.com

songxr@scu.edu.cn

Received Date: 21 June 2022
Revised Date: 22 October 2022
Accepted Date: 24 October 2022
Available Online: 27 October 2022

Figures(4)

Hypertension is the leading risk factor for death and disability, and hypertensive patients always need long-term oral antihypertensive drugs. Some bioactive peptides that extracted from animals or plants have shown excellent advantages on antihypertension. However, the oral delivery of these peptides is always failure on account of instability and poor absorption in the gastrointestinal tract. Herein, we developed a core-shell lipid-polymeric nanoparticle for oral delivery of a highly efficient antihypertensive peptide KY5 (KY5-CSs). KY5-CSs had a particle size of 216.7 ± 2.5 nm, with a narrow PDI of 0.07 ± 0.01. The zeta potential was −4.1 ± 0.1 mV. It exhibited good stability in 4 °C and possessed a controlled release behavior in gastrointestinal tract. The cellular uptake study proved that the lipid shell imparted unique capability of permeation across the mucus layer and internalization by Caco-2/HT-29 cells. In addition, KY5-CSs enhanced in situ intestinal absorption in SD rats. The pharmacokinetic studies and antihypertensive efficacy showed a superior oral absorption and antihypertensive effect of KY5-CSs than KY5-NPs. In conclusion, the core-shell lipid-polymeric nanoparticles will provide attractive potential for oral delivery of antihypertensive peptides.
- Hypertension,
- Core-shell lipid-polymeric nanoparticles,
- KY5,
- Antihypertensive peptides,
- Oral delivery
1. [1]
  R.R. Dhungana, Z. Pedisic, M. Dhimal, B. Bista, M. de Courten, Glob. Health Action 15 (2022) 2000092. doi: 10.1080/16549716.2021.2000092
2. [2]
  P. Nugroho, H. Andrew, K. Kohar, C.A. Noor, A.L. Sutranto, Ann. Med. 54 (2022) 837-845. doi: 10.1080/07853890.2022.2044510
3. [3]
  L. Xue, X. Wang, Z. Hu, et al., Peptides 99 (2018) 161-168. doi: 10.1016/j.peptides.2017.09.021
4. [4]
  Q. Wu, Y. Li, K. Peng, et al., J. Agr. Food. Chem. 67 (2019) 8149-8159. doi: 10.1021/acs.jafc.9b02276
5. [5]
  Y. Zheng, X. Wang, Y. Zhuang, et al., Molecules (Basel, Switzerland) 24 (2019) 4562. doi: 10.3390/molecules24244562
6. [6]
  A. Ganguly, K. Sharma, K. Majumder, Adv. Food. Nutr. Res. 89 (2019) 165-207.
7. [7]
  J. Gao, Q. Liu, L. Zhao, et al., J. Agr. Food. Chem. 69 (2021) 146-158. doi: 10.1021/acs.jafc.0c04232
8. [8]
  T. Ji, Y. Li, X. Deng, et al., Nat. Biomed. Eng. 5 (2021) 1099-1109. doi: 10.1038/s41551-021-00793-y
9. [9]
  Y. Liu, D. Li, J. Ding, X. Chen, Chin. Chem. Lett. 31 (2020) 3001-3014. doi: 10.1016/j.cclet.2020.04.029
10. [10]
  D.J. Drucker, Nat. Rev. Drug. Discov. 19 (2020) 277-289. doi: 10.1038/s41573-019-0053-0
11. [11]
  P. Lundquist, P. Artursson, Adv. Drug. Delivery. Rev. 106 (2016) 256-276. doi: 10.1016/j.addr.2016.07.007
12. [12]
  Q. Zhu, Z. Chen, P.K. Paul, et al., Acta. Pharm. Sin. B 11 (2021) 2416-2448. doi: 10.1016/j.apsb.2021.04.001
13. [13]
  S. Haddadzadegan, F. Dorkoosh, A. Bernkop-Schnürch, Adv. Drug. Delivy. Rev. 182 (2022) 114097. doi: 10.1016/j.addr.2021.114097
14. [14]
  A. des Rieux, V. Fievez, M. Garinot, Y.J. Schneider, V. Préat, J. Control. Release. 116 (2006) 1-27. doi: 10.1016/j.jconrel.2006.08.013
15. [15]
  V.V. Khutoryanskiy, Adv. Drug. Deliv. Rev. 124 (2018) 140-149. doi: 10.1016/j.addr.2017.07.015
16. [16]
  X. Han, Y. Lu, J. Xie, et al., Nat. Nanotechnol. 15 (2020) 605-614. doi: 10.1038/s41565-020-0693-6
17. [17]
  M. Liu, X. Zhong, Z. Yang, Sci. Rep. 7 (2017) 41322. doi: 10.1038/srep41322
18. [18]
  P. Uhl, C. Grundmann, M. Sauter, et al., Nanomed-Nanotechnol. 24 (2020) 102132. doi: 10.1016/j.nano.2019.102132
19. [19]
  J. Sheng, H. He, L. Han, et al., J. Control. Release 233 (2016) 181-190. doi: 10.1016/j.jconrel.2016.05.015
20. [20]
  K. Wang, Y. Feng, S. Li, et al., J. Biomed. Nanotechnol. 14 (2018) 1806-1815. doi: 10.1166/jbn.2018.2618
21. [21]
  J. Xu, Y. Zhang, J. Xu, et al., Biomaterials 216 (2019) 119247. doi: 10.1016/j.biomaterials.2019.119247
22. [22]
  H. Sun, D. Liu, Y. Li, X. Tang, Y. Cong, Int. J. Nanomed. 9 (2014) 1709-1716.
23. [23]
  P.M. Castro, P. Baptista, A.R. Madureira, B. Sarmento, M.E. Pintado, Int. J. Pharmaceut. 547 (2018) 593-601. doi: 10.1016/j.ijpharm.2018.05.051
24. [24]
  S. Kecel-Gündüz, Y. Budama-Kilinc, R. C. Koc, et al., J. Biomol. Struct. Dyn. 36 (2018) 2893-2907. doi: 10.1080/07391102.2017.1371644
25. [25]
  T. Yu, S. Zhao, Z. Li, et al., Int. J. Mol. Sci. 17 (2016) 1977-1989. doi: 10.3390/ijms17121977
26. [26]
  P. Ahlin, J. Kristl, A. Kristl, F. Vrecer, Int. J. Pharmaceut. 239 (2002) 113-120. doi: 10.1016/S0378-5173(02)00076-5
27. [27]
  M. Yu, L. Xu, F. Tian, et al., Nat. Commun. 9 (2018) 2607. doi: 10.1038/s41467-018-05061-3
28. [28]
  Y. Zheng, L. Xing, L. Chen, et al., Biomaterials 262 (2020) 120323. doi: 10.1016/j.biomaterials.2020.120323
29. [29]
  L. Zhang, Q. Feng, J. Wang, et al., ACS Nano 9 (2015) 9912-9921. doi: 10.1021/acsnano.5b05792
30. [30]
  S. Krishnamurthy, R. Vaiyapuri, L. Zhang, J.M. Chan, Biomater. Sci. 3 (2015) 923-936. doi: 10.1039/C4BM00427B
31. [31]
  X. Liu, X. Zhong, C. Li, Chin. Chem. Lett. 32 (2021) 2347-2358. doi: 10.1016/j.cclet.2021.03.015
32. [32]
  Chunxiong Zheng, M. Li, Jianxun Ding. BIO Integration 2 (2021) 57–60. doi: 10.15212/bioi-2021-0016
33. [33]
  X. Zhu, J. Wu, W. Shan, et al., Adv. Funct. Mater. 26 (2016) 2728-2738. doi: 10.1002/adfm.201505000
34. [34]
  Y. Zhang, H. Li, Q. Wang, et al., Adv. Funct. Mater. 28 (2018) 1-15.
35. [35]
  Q. Xu, L.M. Ensign, N.J. Boylan, et al., ACS Nano 9 (2015) 9217-9227. doi: 10.1021/acsnano.5b03876
36. [36]
  F. Ravar, E. Saadat, M. Gholami, et al., J. Control. Release 229 (2016) 10-22. doi: 10.1016/j.jconrel.2016.03.012
37. [37]
  F. Danhier, E. Ansorena, J.M. Silva, et al., J. Control. Release 161 (2012) 505-522. doi: 10.1016/j.jconrel.2012.01.043
38. [38]
  S.S. Lee, Y.B. Lee, I.J. Oh, J. Pharm. Investig. 45 (2015) 1-9. doi: 10.1007/s40005-014-0165-9
39. [39]
  L. Liu, W. Yao, X. Xie, J. Gao, X. Lu, J. Nanobiotechnol. 19 (2021) 235. doi: 10.1186/s12951-021-00974-6
40. [40]
  R. Mo, X. Jin, N. Li et al., Biomaterials 32 (2011) 4609-4620. doi: 10.1016/j.biomaterials.2011.03.005
41. [41]
  W. De Haes, G. Van Mol, C. Merlin, et al., Mol. Pharmaceut. 9 (2012) 2942-2949. doi: 10.1021/mp3003336
42. [42]
  J. Cao, X. Xie, A. Lu, et al., Biomaterials 35 (2014) 4517-4524. doi: 10.1016/j.biomaterials.2014.01.067
43. [43]
  A. García-Rodríguez, L. Vila, C. Cortés, A. Hernández, R. Marcos, Food. Chem. Toxicol. 113 (2018) 162-170. doi: 10.1016/j.fct.2018.01.042
44. [44]
  J. Wu, Y. Zheng, M. Liu, et al., ACS. Appl. Mater. Interfaces. 10 (2018) 9916-9928. doi: 10.1021/acsami.7b16524
45. [45]
  S. Zhao, J. Li, F. Wang, et al., Chin. Chem. Lett. 31 (2020) 1147-1152. doi: 10.1109/ispec50848.2020.9351076
1. [1]
  Fengjie Liu , Fansu Meng , Zhenjiang Yang , Huan Wang , Yuehong Ren , Yu Cai , Xingwang Zhang . Exosome-biomimetic nanocarriers for oral drug delivery. Chinese Chemical Letters, 2024, 35(9): 109335-. doi: 10.1016/j.cclet.2023.109335
2. [2]
  Linghui Zou , Meng Cheng , Kaili Hu , Jianfang Feng , Liangxing Tu . Vesicular drug delivery systems for oral absorption enhancement. Chinese Chemical Letters, 2024, 35(7): 109129-. doi: 10.1016/j.cclet.2023.109129
3. [3]
  Qin Yu , Haisheng He , Jianping Qi , Yi Lu , Wei Wu . Oral delivery of insulin by barbed microneedles actuated by intestinal peristalsis. Chinese Chemical Letters, 2024, 35(9): 109888-. doi: 10.1016/j.cclet.2024.109888
4. [4]
  Lu Li , Suticha Chunta , Xianzi Zheng , Haisheng He , Wei Wu , Yi Lu . β-Lactoglobulin stabilized lipid nanoparticles enhance oral absorption of insulin by slowing down lipolysis. Chinese Chemical Letters, 2024, 35(4): 108662-. doi: 10.1016/j.cclet.2023.108662
5. [5]
  Shaonan Tian , Yu Zhang , Qing Zeng , Junyu Zhong , Hui Liu , Lin Xu , Jun Yang . Core-shell gold-copper nanoparticles: Evolution of copper shells on gold cores at different gold/copper precursor ratios. Chinese Journal of Structural Chemistry, 2023, 42(11): 100160-100160. doi: 10.1016/j.cjsc.2023.100160
6. [6]
  Hengying Xiang , Nanping Deng , Lu Gao , Wen Yu , Bowen Cheng , Weimin Kang . 3D core-shell nanofibers framework and functional ceramic nanoparticles synergistically reinforced composite polymer electrolytes for high-performance all-solid-state lithium metal battery. Chinese Chemical Letters, 2024, 35(8): 109182-. doi: 10.1016/j.cclet.2023.109182
7. [7]
  Min Song , Qian Zhang , Tao Shen , Guanyu Luo , Deli Wang . Surface reconstruction enabled o-PdTe@Pd core-shell electrocatalyst for efficient oxygen reduction reaction. Chinese Chemical Letters, 2024, 35(8): 109083-. doi: 10.1016/j.cclet.2023.109083
8. [8]
  Yuan Zhang , Shenghao Gong , A.R. Mahammed Shaheer , Rong Cao , Tianfu Liu . Plasmon-enhanced photocatalytic oxidative coupling of amines in the air using a delicate Ag nanowire@NH₂-UiO-66 core-shell nanostructures. Chinese Chemical Letters, 2024, 35(4): 108587-. doi: 10.1016/j.cclet.2023.108587
9. [9]
  Luyu Zhang , Zirong Dong , Shuai Yu , Guangyue Li , Weiwen Kong , Wenjuan Liu , Haisheng He , Yi Lu , Wei Wu , Jianping Qi . Ionic liquid-based in situ dynamically self-assembled cationic lipid nanocomplexes (CLNs) for enhanced intranasal siRNA delivery. Chinese Chemical Letters, 2024, 35(7): 109101-. doi: 10.1016/j.cclet.2023.109101
10. [10]
  Wenjia Wang , Xingyue He , Xiaojie Wang , Tiantian Zhao , Osamu Muraoka , Genzoh Tanabe , Weijia Xie , Tianjiao Zhou , Lei Xing , Qingri Jin , Hulin Jiang . Glutathione-depleted cyclodextrin pseudo-polyrotaxane nanoparticles for anti-inflammatory oxaliplatin (Ⅳ) prodrug delivery and enhanced colorectal cancer therapy. Chinese Chemical Letters, 2024, 35(4): 108656-. doi: 10.1016/j.cclet.2023.108656
11. [11]
  Chen Li , Ziyuan Zhao , Shouyun Yu . Photoredox-catalyzed C-glycosylation of peptides with glycosyl bromides. Chinese Chemical Letters, 2024, 35(6): 109128-. doi: 10.1016/j.cclet.2023.109128
12. [12]
  Dake Liu , Shuyan Liu , Fanlei Hu , Zhongtang Li , Zhongjun Li . N-Glycosylated type Ⅱ collagen peptides as therapeutic saccharide vaccines for rheumatoid arthritis. Chinese Chemical Letters, 2024, 35(5): 108762-. doi: 10.1016/j.cclet.2023.108762
13. [13]
  Guo-Hong Gao , Run-Ze Zhao , Ya-Jun Wang , Xiao Ma , Yan Li , Jian Zhang , Ji-Sen Li . Core–shell heterostructure engineering of CoP nanowires coupled NiFe LDH nanosheets for highly efficient water/seawater oxidation. Chinese Chemical Letters, 2024, 35(8): 109181-. doi: 10.1016/j.cclet.2023.109181
14. [14]
  Yiran Tao , Chunlei Dai , Zhaoxiang Xie , Xinru You , Kaiwen Li , Jun Wu , Hai Huang . Redox responsive polymeric nanoparticles enhance the efficacy of cyclin dependent kinase 7 inhibitor for enhanced treatment of prostate cancer. Chinese Chemical Letters, 2024, 35(8): 109170-. doi: 10.1016/j.cclet.2023.109170
15. [15]
  Shulei Hu , Yu Zhang , Xiong Xie , Luhan Li , Kaixian Chen , Hong Liu , Jiang Wang . Rh(Ⅲ)-catalyzed late-stage C-H alkenylation and macrolactamization for the synthesis of cyclic peptides with unique Trp(C7)-alkene crosslinks. Chinese Chemical Letters, 2024, 35(8): 109408-. doi: 10.1016/j.cclet.2023.109408
16. [16]
  Jing Zhang , Charles Wang , Yaoyao Zhang , Haining Xia , Yujuan Wang , Kun Ma , Junfeng Wang . Application of magnetotactic bacteria as engineering microrobots: Higher delivery efficiency of antitumor medicine. Chinese Chemical Letters, 2024, 35(10): 109420-. doi: 10.1016/j.cclet.2023.109420
17. [17]
  Ke Wang , Jia Wu , Shuyi Zheng , Shibin Yin . NiCo Alloy Nanoparticles Anchored on Mesoporous Mo2N Nanosheets as Efficient Catalysts for 5-Hydroxymethylfurfural Electrooxidation and Hydrogen Generation. Chinese Journal of Structural Chemistry, 2023, 42(10): 100104-100104. doi: 10.1016/j.cjsc.2023.100104
18. [18]
  Wen Xiao , Fazhan Wang , Yangzhuo Gu , Xi He , Na Fan , Qian Zheng , Shugang Qin , Zhongshan He , Yuquan Wei , Xiangrong Song . PEG400-mediated nanocarriers improve the delivery and therapeutic efficiency of mRNA tumor vaccines. Chinese Chemical Letters, 2024, 35(5): 108755-. doi: 10.1016/j.cclet.2023.108755
19. [19]
  Ningyue Xu , Jun Wang , Lei Liu , Changyang Gong . Injectable hydrogel-based drug delivery systems for enhancing the efficacy of radiation therapy: A review of recent advances. Chinese Chemical Letters, 2024, 35(8): 109225-. doi: 10.1016/j.cclet.2023.109225
20. [20]
  Qiang Li , Jiangbo Fan , Hongkai Mu , Lin Chen , Yongzhen Yang , Shiping Yu . Nucleus-targeting orange-emissive carbon dots delivery adriamycin for enhanced anti-liver cancer therapy. Chinese Chemical Letters, 2024, 35(6): 108947-. doi: 10.1016/j.cclet.2023.108947

Get Citation

PDF

XML

Metrics

PDF Downloads(9)
Abstract views(339)
HTML views(43)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142